CSIMarket
 
Sera Prognostics Inc   (NASDAQ: SERA)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Sera Prognostics Inc's Customers Performance

SERA



 
SERA's Source of Revenues During the corresponding time, Sera Prognostics Inc recorded a revenue increase by 76.47 % year on year, sequentially revenue grew by 114.29 %. While revenue at the Sera Prognostics Inc 's corporate clients

List of SERA Customers




for the same period Sera Prognostics Inc recorded revenue increase by 76.47 % year on year, sequentially revenue grew by 114.29 %.

List of SERA Customers

Sera Prognostics Inc's Business Units






Sera Prognostics Inc's Comment on Sales, Marketing and Customers



The company provides health care providers and payers with the PreTRM test-and-treat strategy to predict and manage pregnancy-related conditions. Its customers include institutions that have adopted the PreTRM test, supported by clinical efficacy and health economic savings data from studies such as the AVERT PRETERM TRIAL and the PRIME study. The company targets the pregnancy health market, focusing on women and their babies. Its products are developed using a proprietary technology platform and a biobank that includes specimens from a diverse U.S. pregnant population as well as global samples. The company's activities encompass the discovery, development, and commercialization of biomarker and predictive analytic tests for major pregnancy conditions.





Sera Prognostics Inc’s Comment on Sales, Marketing and Customers


The company provides health care providers and payers with the PreTRM test-and-treat strategy to predict and manage pregnancy-related conditions. Its customers include institutions that have adopted the PreTRM test, supported by clinical efficacy and health economic savings data from studies such as the AVERT PRETERM TRIAL and the PRIME study. The company targets the pregnancy health market, focusing on women and their babies. Its products are developed using a proprietary technology platform and a biobank that includes specimens from a diverse U.S. pregnant population as well as global samples. The company's activities encompass the discovery, development, and commercialization of biomarker and predictive analytic tests for major pregnancy conditions.








SERA's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Sera Prognostics Inc 101.96 0.06 -32.14 72
SUBTOTAL 0.00 0.00 0.00 -

Sources: Sera Prognostics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Sera Prognostics Inc’s corporate clients.
For your research, we’ve provided 9 tables on Sera Prognostics Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.